gefitinib (Iressa)

DRUG5 trials

Sponsors

Telik, AstraZeneca, Chinese Society of Lung Cancer, Assistance Publique - Hôpitaux de Paris

Conditions

Brain MetastasisCancerEGFR-mutated Lung AdenocarcinomaNeoplasms, Squamous CellNon Small Cell Lung CancerNon Small Cell Lung Carcinoma

Phase 2

IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma

CompletedNCT00229723

AstraZenecaNeoplasms, Squamous Cell

Start: 2004-11-30End: 2008-06-30Updated: 2009-08-04

IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma

CompletedNCT00229723

AstraZenecaNeoplasms, Squamous Cell

Start: 2004-11-30End: 2008-06-30Updated: 2009-08-04

Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations

CompletedNCT00891579

Chinese Society of Lung CancerNon Small Cell Lung Cancer

Start: 2009-02-28End: 2012-11-30Updated: 2012-12-10

Phase 3

Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

CompletedNCT00080340

TelikNon Small Cell Lung Carcinoma

End: 2005-05-31Target: 520Updated: 2008-01-15

Open-Label Extension of Other SZ1839 (Iressa) Trials

CompletedNCT00635973

AstraZenecaCancer

Start: 2000-02-29End: 2003-10-31Target: 100Updated: 2009-04-22

Unknown Phase

Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis

TerminatedNCT01363557

Assistance Publique - Hôpitaux de ParisBrain Metastasis, EGFR-mutated Lung Adenocarcinoma

Start: 2012-03-31End: 2013-05-31Updated: 2014-05-13

Related Papers

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial.

2014-10-0350 citations